XTNT News and Press, Xtant Medical Holdings Inc. From 05/04/23

Initiates Annual Revenue Guidance of $73 Million - $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, tod...

BELGRADE, Mont., April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended M...

2023-03-07 15:03:02 ET Xtant Medical Holdings, Inc. (XTNT) Q4 2022 Earnings Conference Call March 07, 2023 09:00 AM ET Company Participants Matt Steinberg - IR, FINN Partners Sean Browne - President and Chief Executive Officer Scott Niels - Chief Financial Office...

2023-03-07 07:04:44 ET Xtant Medical press release ( NYSE: XTNT ): Q4 GAAP EPS of -$0.02. Revenue of $15.27M (+9.3% Y/Y). For further details see: Xtant Medical GAAP EPS of -$0.02, revenue of $15.27M

BELGRADE, Mont., March 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended Dec...

BELGRADE, Mont., March 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and fu...

Xtant Medical ( NYSE: XTNT ) and Surgalign ( NASDAQ: SRGA ) entered into a definitive agreement and subsequently closed on the transaction wherein Xtant acquired the Coflex and Cofix product lines from Surgalign for a total consideration of $...

Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Xtant ...

BELGRADE, Mont., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord ...

BELGRADE, Mont., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Mark Schallenberger as Chief Operations Officer, effec...